Pharmaco kinetics and tissue distribution of enrofloxacin and its metabolite ciprofloxacin in the Chinese mitten-handed crab, Eriocheir sinensis

被引:32
作者
Wu, Guanghong [1 ]
Meng, Yong [1 ]
Zhu, Xiaohua [1 ]
Huang, Cheng [1 ]
机构
[1] Freshwater Fisheries Res Inst Jiangsu Province, Nanjing 210017, Peoples R China
关键词
enrofloxacin; ciprofloxacin; Eriocheir sinensis; pharmacokinetics;
D O I
10.1016/j.ab.2006.05.031
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin were investigated in the Chinese mitten-handed crab after a single intramuscular injection of enrofloxacin at 5.0 mg/kg body weight. The tissue concentrations of enrofloxacin and ciprofloxacin were determined simultaneously by a high-performance liquid chromatography (HPLC) method. The data were analyzed with Practical Pharmacokinctic Program 3P97. The highest average concentrations of enrofloxacin in liver, muscle, gill, and hemolymph were 3.93, 12.42, 16.73, and 11.04 mu g/g (ml), respectively. The elimination half-lives (t(1/2 beta)) for enrofloxacin were 92.42, 64.86, 38.80, and 52.39 h, respectively. The AUC(0-infinity) values for enrofloxacin were 304.80, 260.74, 288.30, and 269.24 mu g h/ml, respectively. Ciprofloxacin could be detected in all four tissues. The respective values of main pharmacokinetics parameters C-max, t(1/2 beta), and AUC(0-infinity) were 0.52 mu g/g (ml), 38.38 h,and 35.06 mu g h/ml for liver; 0.24 mu g/g (ml), 65.36 h, and 25.64 mu g h/ml for muscle; 0.10 mu g/g (ml), 112.88 h,and 11.57 mu g h/ml for gill; and 0.30 mu g/g (ml), 93.33 h, and 39.99 mu g h/ml for hemolymph. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:25 / 30
页数:6
相关论文
共 15 条
[1]   The single substance and mixture toxicity of quinolones to the bioluminescent bacterium Vibrio fischeri [J].
Backhaus, T ;
Scholze, M ;
Grimme, LH .
AQUATIC TOXICOLOGY, 2000, 49 (1-2) :49-61
[2]  
Fang X. X., 2004, J FISH CHINA, V28, P35
[3]   Pharmacokinetics of ciprofloxacin in eels by high-performance liquid chromatography with fluorescence detection [J].
Guo, LQ ;
Xie, ZH ;
Lin, XC ;
Wu, XP ;
Qiu, B ;
Zhang, YB ;
You, HN ;
Chen, GN .
ANALYTICAL BIOCHEMISTRY, 2005, 341 (02) :275-279
[4]   The plasma kinetics and tissue distribution of enrofloxacin and its metabolite ciprofloxacin in the Muscovy duck [J].
Intorre, L ;
Mengozzi, G ;
Bertini, S ;
Bagliacca, M ;
Luchetti, E ;
Soldani, G .
VETERINARY RESEARCH COMMUNICATIONS, 1997, 21 (02) :127-136
[5]   Pharmacokinetics of enrofloxacin in the seabass (Dicentrarchus labrax) [J].
Intorre, L ;
Cecchini, S ;
Bertini, S ;
Varriale, AMC ;
Soldani, G ;
Mengozzi, G .
AQUACULTURE, 2000, 182 (1-2) :49-59
[6]   Pharmacokinetics of enrofloxacin in the red pacu (Colossoma brachypomum) after intramuscular, oral and bath administration [J].
Lewbart, G ;
Vaden, S ;
Deen, J ;
Manaugh, C ;
Whitt, D ;
Doi, A ;
Smith, T ;
Flammer, K .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1997, 20 (02) :124-128
[7]  
Mengozzi G, 1996, AM J VET RES, V57, P1040
[8]   Disposition kinetics of enrofloxacin and ciprofloxacin following intravenous administration of enrofloxacin in goats [J].
Rao, GS ;
Ramesh, S ;
Ahmad, AH ;
Tripathi, HC ;
Sharma, LD ;
Malik, JK .
SMALL RUMINANT RESEARCH, 2002, 44 (01) :9-15
[9]   Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intramuscular administration of enrofloxacin in goats [J].
Rao, GS ;
Ramesh, S ;
Ahmad, AH ;
Tripathi, HC ;
Sharma, LD ;
Malik, JK .
VETERINARY RESEARCH COMMUNICATIONS, 2001, 25 (03) :197-204
[10]  
SCHENTAG DA, 1997, J VET PHARMACOL THER, V20, P111